These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38622454)

  • 1. Investigation of total cerebellar and flocculonodular lobe volume in Parkinson's disease and healthy individuals: a brain segmentation study.
    Ozgen MN; Sahin NE; Ertan N; Sahin B
    Neurol Sci; 2024 Sep; 45(9):4291-4298. PubMed ID: 38622454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of gray matter volume with peripheral cytokines in Parkinson's disease.
    Chen B; Zhou H; Liu X; Yang W; Luo Y; Zhu S; Zheng J; Wei X; Chan LL; Tan EK; Wang Q
    Neurobiol Dis; 2024 Oct; 201():106693. PubMed ID: 39368669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum.
    Morelli N
    Rev Neurol (Paris); 2022 Nov; 178(9):924-931. PubMed ID: 35871015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topologically convergent and divergent morphological gray matter networks in early-stage Parkinson's disease with and without mild cognitive impairment.
    Suo X; Lei D; Li N; Li J; Peng J; Li W; Yang J; Qin K; Kemp GJ; Peng R; Gong Q
    Hum Brain Mapp; 2021 Oct; 42(15):5101-5112. PubMed ID: 34322939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences in cerebellar grey matter volume and disrupted functional connectivity in idiopathic Parkinson's disease and multiple system atrophy.
    Wang N; Zhang L; Yang H; Liu H; Luo X; Fan G
    Neuropsychologia; 2019 Feb; 124():125-132. PubMed ID: 30590063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating Patients with Parkinson's Disease from Normal Controls Using Gray Matter in the Cerebellum.
    Zeng LL; Xie L; Shen H; Luo Z; Fang P; Hou Y; Tang B; Wu T; Hu D
    Cerebellum; 2017 Feb; 16(1):151-157. PubMed ID: 27138531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
    Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
    Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increased gray matter volumes of precentral gyri in Parkinson's disease patients with diphasic dyskinesia.
    Zhi Y; Wang M; Yuan YS; Shen YT; Ma KW; Gan CT; Si QQ; Wang LN; Cao SW; Zhang KZ
    Aging (Albany NY); 2019 Nov; 11(21):9661-9671. PubMed ID: 31699957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease.
    Terada T; Miyata J; Obi T; Kubota M; Yoshizumi M; Murai T
    J Neurol Sci; 2018 Jul; 390():231-238. PubMed ID: 29801896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can volumetric magnetic resonance imaging evaluations be helpful in the follow-up of cognitive functions in cognitively normal Parkinson's disease patients?
    Uysal HA; Hünerli D; Çakmur R; Dönmez Çolakoğlu B; Ada E; Yener G
    Turk J Med Sci; 2024; 54(4):688-699. PubMed ID: 39295615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray Matter Atrophy in Parkinson's Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study.
    Cui X; Li L; Yu L; Xing H; Chang H; Zhao L; Qian J; Song Q; Zhou S; Dong C
    Clinics (Sao Paulo); 2020; 75():e1505. PubMed ID: 32555945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson's disease: an atlas-based correlation analysis.
    Pang H; Li X; Yu Z; Yu H; Bu S; Wang J; Zhao M; Liu Y; Jiang Y; Fan G
    Cereb Cortex; 2024 Oct; 34(10):. PubMed ID: 39420471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
    Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
    PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different patterns of gray matter density in early- and middle-late-onset Parkinson's disease: a voxel-based morphometry study.
    Xuan M; Guan X; Huang P; Shen Z; Gu Q; Yu X; Xu X; Luo W; Zhang M
    Brain Imaging Behav; 2019 Feb; 13(1):172-179. PubMed ID: 28667375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume.
    Hünerli D; Emek-Savaş DD; Çavuşoğlu B; Dönmez Çolakoğlu B; Ada E; Yener GG
    Clin Neurophysiol; 2019 Aug; 130(8):1208-1217. PubMed ID: 31163365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural and dopaminergic correlates of fatigue in Parkinson's disease.
    Kang SY; Bang M; Hong JY; Oh J; Kim JS; Han YM; Chang SK; Lee SA; Yoon U; Shin NY
    J Neural Transm (Vienna); 2020 Mar; 127(3):301-309. PubMed ID: 31894419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter volume alterations in de novo Parkinson's disease: A mediational role in the interplay between sleep quality and anxiety.
    He G; Huang X; Sun H; Xing Y; Gu S; Ren J; Liu W; Lu M
    CNS Neurosci Ther; 2024 Jul; 30(7):e14867. PubMed ID: 39031989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.